Rna

Dr Sewanti Limaye, Director, Precision Oncology, HN Reliance Hospital and Research Centre. Cancer is among the most researched diseases in the world. For most cancers, early detection is rare, and there isn’t enough consensus among oncologists, researchers and practitioners of non-Western medicine on its exact causes. Overall, a few broad causes have been conclusively established: Cancer may arise as a consequence of genomic abnormalities such as mutations, or when the body’s immune system weakens or collapses, or due to external assaults to the body such as tobacco use, exposure to chemicals and radiation and certain infections. But much like the human body, much of this disease is a mystery. There is no one cause and there is no one cure. As Pulitzer Prize-winning author and oncologist Siddhartha Mukherjee has written in his cancer magnum opus The Emperor of All Maladies , “That this seemingly simple mechanism—cell growth without barriers—can lie at the heart of this … [Read more...] about World Cancer Day 2023 | Precision oncology is a new way of looking at cancer treatment: Dr Sewanti Limaye

Share to Twitter Share to Linkedin This article is part of a larger series on the risks of molnupiravir. For a summary of the risks at the level of the individual, see here , and for an overview of the risks on a societal level, see here . Mutations to the SARS-CoV-2 genome, especially in the spike protein, help the virus elude vaccines, natural immunity, and monoclonal antibody treatments. Such mutations can also help improve viral fitness, including quicker viral replication, shorter incubation periods, and increased immunosuppressive capabilities. Together, these issues pose a serious challenge to pandemic control. One potential area of hope are antiviral drugs. Unfortunately, none of our current options are effective in preventing infection. In fact, one of the more widely-used drugs against Covid-19 —molnupiravir— may supercharge viral mutation and spawn new variants. When I first voiced this concern , it was sidelined as largely … [Read more...] about Taking A Closer Look At Molnupiravir. Is Continued Use Justified?